Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Table 1 Characteristics of the study cohorts

From: Serum microRNA qPCR profiling and validation indicate upregulation of circulating miR-145-5p and miR-26a-5p in migraineurs

 

Screening cohort

Validation cohort

Number

13

26

Female: male

11:2

23:3

Age (years)

24–63, median: 43, SD: 11.64

19–66, median: 40, SD: 12.31

Diagnoses

EM: 8 EMA: 4 CM: 1

EM: 11 EMA: 10 CM: 3 CMA: 2

Nonictal: ictal phase

9:4

21:5

  1. CM – chronic migraine without aura, CMA – chronic migraine with aura, EM – episodic migraine without aura, EMA – episodic migraine with aura, SD – standard deviation
Back to article page

The Journal of Headache and Pain

ISSN: 1129-2377

Contact us